New COVID-19 drug shows greater promise against resistant viral strains

by

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *